Literature DB >> 11971264

Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus.

Maria Mavris1, Anne-Laure Page, Régis Tournebize, Brigitte Demers, Philippe Sansonetti, Claude Parsot.   

Abstract

The virulence plasmid-encoded type III secretion system of Shigella flexneri consists of the Mxi-Spa secretion apparatus, secreted proteins IpaA-D and IpgD involved in entry of bacteria into epithelial cells,cytoplasmic chaperones IpgC and IpgE and 15 other secreted proteins of unknown function, including VirA and members of the IpaH family. The activity of the Mxi-Spa apparatus is regulated by external signals, and transcription of virA and IpaH genes is specifically induced in conditions of active secretion. We present genetic evidence that regulation of these genes involves both MxiE, the transcriptional activator of the AraC family encoded by the mxi operon, and IpgC, the chaperone for IpaB and IpaC. We also show that together MxiE and IpgC are sufficient to activatevirA and IpaH 9.8 promoters in Escherichia coli. InS. flexneri, increasing the expression of IpgC led to a concomitant increase in IpaH production in conditions of non-secretion. This suggests that the activity of secretion is sensed by the presence of free IpgC, which acts as a coactivator to allow MxiE to activate transcription at its target promoters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971264     DOI: 10.1046/j.1365-2958.2002.02836.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  70 in total

Review 1.  Type III secretion systems and bacterial flagella: insights into their function from structural similarities.

Authors:  Ariel Blocker; Kaoru Komoriya; Shin-Ichi Aizawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

2.  Translocated intimin receptor and its chaperone interact with ATPase of the type III secretion apparatus of enteropathogenic Escherichia coli.

Authors:  Annick Gauthier; B Brett Finlay
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

Review 3.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

Review 4.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

5.  ExsA recruits RNA polymerase to an extended -10 promoter by contacting region 4.2 of sigma-70.

Authors:  Christopher A Vakulskas; Evan D Brutinel; Timothy L Yahr
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

6.  Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation.

Authors:  Da-Kang Shen; Saroj Saurya; Carolin Wagner; Hiroaki Nishioka; Ariel J Blocker
Journal:  Infect Immun       Date:  2010-10-11       Impact factor: 3.441

Review 7.  Type III secretion systems: the bacterial flagellum and the injectisome.

Authors:  Andreas Diepold; Judith P Armitage
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-05       Impact factor: 6.237

Review 8.  Process of protein transport by the type III secretion system.

Authors:  Partho Ghosh
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

9.  Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases.

Authors:  Alexander U Singer; John R Rohde; Robert Lam; Tatiana Skarina; Olga Kagan; Rosa Dileo; Nickolay Y Chirgadze; Marianne E Cuff; Andrzej Joachimiak; Mike Tyers; Philippe J Sansonetti; Claude Parsot; Alexei Savchenko
Journal:  Nat Struct Mol Biol       Date:  2008-11-09       Impact factor: 15.369

10.  The extreme C terminus of Shigella flexneri IpaB is required for regulation of type III secretion, needle tip composition, and binding.

Authors:  A Dorothea Roehrich; Isabel Martinez-Argudo; Steven Johnson; Ariel J Blocker; Andreas K J Veenendaal
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.